Journal: Diabetes Spectrum : A Publication of the American Diabetes Association

Article Title: Management of Adults With Diabetes and Cognitive Problems

doi: 10.2337/ds16-0035

Figure Lengend Snippet: Assistive Devices for People With Diabetes and Cognitive Impairment and Their Caregivers

Article Snippet: CGM devices , 1. CGM devices for personal wear (e.g., Dexcom G5, Medtronic Enlite, or Medtronic Guardian): alert patients or caregivers to fluctuating blood glucose levels and blood glucose levels that are above or below preset parameters. The share feature of the Dexcom G5 might be particularly useful in patients with cognitive impairment. 2. mySentry Remote Glucose Monitor: a device that displays a patient’s blood glucose levels but can be set up in a caretaker’s room. Customizable alarms can be set to alert the caregiver to dangerous glucose levels. 3. CGM devices for professional use (e.g., Dexcom G4 Platinum professional or Medtronic iPro2 Professional CGM: used to track a patient’s glucose levels for a designated number of days; data downloading allows the medical provider to see glucose trends, glycemic excursions, and problematic glucose patterns and direct changes in therapy to address them..

Techniques: Medications, Stripping Membranes

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Summary of Included Studies

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques: Biomarker Discovery, Control, Injection

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Results of the Economic Literature Review—Summary

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Disease Interventions and Comparators Evaluated in the Primary Economic Model

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Mean A1C Levels, Changes From Baseline With Continuous Glucose Monitoring a

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Calculation of Risk Reduction Owing to a Decrease in A1C Level

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Change in A1C From Baseline and Risk Reduction for Diabetes Complications

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Average Annual Per-Patient Cost of Diabetes Complications and Interventions in Ontario

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Daily and Annual Costs of Diabetes Treatment Supplies a

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Annual Costs of Continuous Glucose Monitoring and Insulin Pump a

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques: Battery

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Costs of Different Diabetes Treatment Technologies a

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Cost to Patient of Technologies With Various Levels of Government Funding

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Base Case Analysis

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 1 Results a

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 2 Results

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 3 Results

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 4 Results

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Scenario 5 Results

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Number of Current Users of Continuous Glucose Monitoring in Ontario by Age Group

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Manufacturer Projections

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Estimated Annual Number of Patients Using Continuous Glucose Monitoring in Ontario, Conservative Projections

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Continuous Glucose Monitoring Device Cost Reduction Scenarios

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Ontario Health Technology Assessment Series

Article Title: Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

doi:

Figure Lengend Snippet: Reasons for Including Four Interventions in the Primary Economic Analysis

Article Snippet: Standalone CGM + MDI (Dexcom G5 Mobile) , 2 , $0.73 , $1.46 , 4 , $0.10 , $0.40 , 4 , $0.40 , $1.60 , $3.46 , $1,263.

Techniques:

Journal: Journal of Clinical Medicine

Article Title: Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes: A Systematic Review and Meta-Analysis

doi: 10.3390/jcm10112445

Figure Lengend Snippet: Generals study characteristics.

Article Snippet: [ ] (d) , 2018 , Crossover RCT , 20 , 34.5 ± 4.7 , 83.3 ± 16.7 , 78.3 ± 18.9 , Tandem t:slim pump Dexcom G5 CGM (single hormone) , Fading memory proportional-derivative , Predictive low glucose suspend: t:slim pump, Dexcom G5 CGM , Running , 45 min , Moderate-intensity.

Techniques: Control